by TrN2016_SandWich | Apr 12, 2016 |
David Tuffin Dr. Tuffin’s area of professional expertise is the biological sciences (biochemistry / pharmacology / physiology) as applied to preclinical research and development in the pharmaceutical industry; primarily in the discovery and development of small...
by TrN2016_SandWich | Apr 12, 2016 |
Gilles Hanton Gilles Hanton graduated as Doctor in Veterinary Medicine in 1976 and as Diplomate of the American Board of Toxicology in 1990. After academic activities, he started his career in the Pharmaceutical Industry in 1984 and worked first for 2.5 years as...
by TrN2016_SandWich | Apr 12, 2016 |
Elizabeth Peers Elizabeth Peers has worked in clinical development since 1983, starting at Astra, initially in respiratory and cardiovascular phase 3/4 development before moving to gastrointestinal (omeprazole); she followed this with 17 years working in...
by TrN2016_SandWich | Apr 12, 2016 |
Stanley Roberts Dr. Stan Roberts is currently an independent consultant in toxicology, drug metabolism (ADME), pharmacokinetics (PK) and drug development. He has over 30 years in scientific and management positions in large (Sandoz, Abbott & Pfizer) and small...
